#therapies

-Cybin Inc. (the “Company”) doing business as Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) ...

ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive ...

DKSH Business Unit Healthcare has developed its "2025 Whitepaper Series on Commercial Go-To-Model Trends", ...

The Health Ministry stated that they will assess the use and funding coverage by the national health insurance ...

 Shanghai, November 10, 2025 – During the 8th China International Import Expo (CIIE), Sino ...

The Ritz-Carlton, Millenia Singapore is pleased to announce the Southeast Asia debut of innovative, ...

The Investment Management Agency of Daya Anagata Nusantara (Danantara Indonesia) has signed a Memorandum of ...

The National University Hospital (NUH) and the Yong Loo Lin School of Medicine, National ...

 The Asia Pacific Cardiovascular Disease Alliance (APAC CVD Alliance), in collaboration with Deloitte, has ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the 5L DynaDrive Single-Use ...

Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision ...

The Ministry of Tourism stated that the tourism sector could be the answer for several parties harboring concerns about ...

- AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs ...

- PHC Corporation’s Biomedical Division (headquarters: Minato-ku, Tokyo, President: Nobuaki Nakamura, hereafter ...

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...